ASH guidelines and the implementation strategies for the prevention of cancer-associated VTE

D-Rd improves long-term survival in transplant-ineligible NDMM patients: An update from the MAIA study

Oral-AZA maintenance treatment shows improved survival outcomes in AML patients: The QUAZAR AML-001 trial

ALR triple regimen elicits a high CR rate among patients with treatment-naïve MCL and allows treatment de-escalation with real-time RMD monitoring

Response-based ponatinib dosing regimens show long-term responses and safety among cp-cml patients: the 3-year update of the OPTIC trial

Blinatumomab-chemotherapy consolidation improves os in adults with MRD- BCR::ABL- b-ALL

R² regimen continues to show survival benefits in patients with RR iNHL: Long-term follow-up from the augment study

The redundant burden of restricted diet in neutropenia patients following SCT